Bio-Rad Laboratories (BIO) Long-Term Investments (2012 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Long-Term Investments of $5.3 billion for Q1 2026, up 6.36% year-over-year from $5.0 billion in Q1 2025, and down 12.97% quarter-over-quarter from $6.1 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Long-Term Investments (2012 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Long-Term Investments for 15 consecutive years, with $5.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Investments rose 6.36% year-over-year to $5.3 billion; the TTM figure through Mar 2026 stood at $5.3 billion (up 6.36% YoY), while the FY2025 annual figure was $6.1 billion, up 26.13% from the prior year.
- Long-Term Investments eased to $5.3 billion in Q1 2026 per BIO's latest filing, from $6.1 billion in the prior quarter.
- Across five years, Long-Term Investments topped out at $9.7 billion in Q1 2022 and bottomed at $4.8 billion in Q4 2024.
- Historically, Long-Term Investments has averaged $6.8 billion across 5 years, with a median of $7.2 billion in 2023.
- Annual changes were most pronounced in 2022 — Long-Term Investments plunged 54.04% — and 2025, when it advanced 26.13%.
- Bio-Rad Laboratories' Long-Term Investments stood at $8.8 billion in 2022, then fell by 12.83% to $7.7 billion in 2023, then plunged by 37.14% to $4.8 billion in 2024, then climbed by 26.13% to $6.1 billion in 2025, then declined by 12.97% to $5.3 billion in 2026.
- Business Quant data shows BIO's Long-Term Investments at $5.3 billion in Q1 2026, $6.1 billion in Q4 2025, and $5.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.49 Bn | 345.80 Mn | 5.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.72 Bn |
| Mar 31, 2026 | 5.31 Bn |
| Dec 31, 2025 | 6.10 Bn |
| Sep 30, 2025 | 5.06 Bn |
| Jun 30, 2025 | 5.58 Bn |
| Mar 31, 2025 | 4.99 Bn |
| Dec 31, 2024 | 4.84 Bn |
| Sep 30, 2024 | 6.00 Bn |
| Jun 30, 2024 | 5.10 Bn |
| Mar 31, 2024 | 8.02 Bn |
| Dec 31, 2023 | 7.70 Bn |
| Sep 30, 2023 | 7.22 Bn |
| Jun 30, 2023 | 7.31 Bn |
| Mar 31, 2023 | 8.88 Bn |
| Dec 31, 2022 | 8.83 Bn |
| Sep 30, 2022 | 7.46 Bn |
| Jun 30, 2022 | 8.09 Bn |
| Mar 31, 2022 | 9.69 Bn |
| Dec 31, 2021 | 14.39 Bn |
| Sep 30, 2021 | 16.23 Bn |